Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/17/2010 | US20100152852 Preparation of tissue for meniscal implantation |
06/17/2010 | US20100152421 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same |
06/17/2010 | US20100152301 Treatment of Viral Infections |
06/17/2010 | US20100152294 Assays For Detecting Inhibitors Of Binding Between COX-2 And PDZ Proteins |
06/17/2010 | US20100152214 Novel pyrimidinecarboxamide derivatives |
06/17/2010 | US20100152206 Bicyclic Dihydropyrimidines and Uses Thereof |
06/17/2010 | US20100152204 Treatment for spinal muscular atrophy |
06/17/2010 | US20100152188 Novel Heterocyclic Compounds |
06/17/2010 | US20100152172 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
06/17/2010 | US20100152159 Imidazopyrazine syk inhibitors |
06/17/2010 | US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases |
06/17/2010 | US20100151575 Method of Making Conditioned Media from Kidney Derived Cells |
06/17/2010 | US20100151574 Multipotent progenitor cell derived from adipose tissue |
06/17/2010 | US20100151573 Compositions and methods for delivery of molecules to selectin-ligand-expressing and selectin-expressing cells |
06/17/2010 | US20100151572 Anti-tumoral compositions methods |
06/17/2010 | US20100151571 Centimeter-scale, integrated diagnostics incubator for biological culturing |
06/17/2010 | US20100151570 Systems and methods for vitrifying tissue |
06/17/2010 | US20100151569 Method of producing a population of cells |
06/17/2010 | US20100151568 Definitive endoderm |
06/17/2010 | US20100151537 Modified ethylenediamine-n, n'-disuccinate: ethylenediamine lyase |
06/17/2010 | US20100151536 Biological Synthesis of Difunctional Alkanes from Carbohydrate Feedstocks |
06/17/2010 | US20100151524 Compositions and Methods for Increasing Bone Mineralization |
06/17/2010 | US20100151523 Regulated expression of recombinant proteins from adeno-associated viral vectors |
06/17/2010 | US20100151520 Translation Enhancer Elements Of Genes Encoding Human Tau Protein and Human Alpha-Synuclein Protein |
06/17/2010 | US20100151517 Methods for carrying out the selective evolution of proteins in vivo |
06/17/2010 | US20100151512 Haemolysator |
06/17/2010 | US20100151511 Biological culture assembly |
06/17/2010 | US20100151510 Substrate for cell culture, producing method thereof and screening method for cell culture conditions utilizing the same |
06/17/2010 | US20100151509 Reagent, kit and method for differentating and counting leukocytes |
06/17/2010 | US20100151495 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
06/17/2010 | US20100151491 Chemical surface nanopatterns to increase activity of surface-immobilized biomolecules |
06/17/2010 | US20100151486 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
06/17/2010 | US20100151476 Phenylthiocarbamide (ptc) taste receptor |
06/17/2010 | US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna |
06/17/2010 | US20100151437 Method for isolating cellular products by cryopreservation |
06/17/2010 | US20100151109 Modulation of plant protein levels |
06/17/2010 | US20100151006 Cancer therapy sensitizer |
06/17/2010 | US20100151005 Targeted carriers for intracellular drug delivery |
06/17/2010 | US20100151002 Guggulphospholipid Methods and Compositions |
06/17/2010 | US20100150968 Dna vectors |
06/17/2010 | US20100150962 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
06/17/2010 | US20100150958 Methods and Compositions for Use of a Coccidiosis Vaccine |
06/17/2010 | US20100150950 Human antibodies that bind cd70 and uses thereof |
06/17/2010 | US20100150948 Materials and methods for improved immunoglycoproteins |
06/17/2010 | US20100150945 Anti-mdl-1 antibodies |
06/17/2010 | US20100150940 Anti-igf antibodies |
06/17/2010 | US20100150937 Antagonists of pcsk9 |
06/17/2010 | US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker |
06/17/2010 | US20100150927 Cell death inducer |
06/17/2010 | US20100150926 Fusion protein capable of binding vegf-a and tnf-alpha |
06/17/2010 | US20100150924 Regulation of myelination by nectin-like (necl) molecules |
06/17/2010 | US20100150923 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
06/17/2010 | US20100150916 huTNFR1 Selective Antagonists |
06/17/2010 | US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION |
06/17/2010 | US20100150907 Pro115 antibody compositions and methods of use |
06/17/2010 | US20100150905 Kim-1 antibodies for treatment of th2-mediated conditions |
06/17/2010 | US20100150904 Binding members for ige molecules |
06/17/2010 | US20100150902 Anti-cd151 antibodies and their use in the treatment of cancer |
06/17/2010 | US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
06/17/2010 | US20100150893 Methods of organ regeneration |
06/17/2010 | US20100150889 Polycistronic Vector For Human Induced Pluripotent Stem Cell Production |
06/17/2010 | US20100150887 Tissue Progenitor Cells That Overexpress ERG |
06/17/2010 | US20100150886 Method of Producing Lymphocytes |
06/17/2010 | US20100150885 Methods and compositions for inducing brown adipogenesis |
06/17/2010 | US20100150883 Stem cells treated by in vitro fucosylation and methods of use |
06/17/2010 | US20100150880 Isolated mesenchymal cell population and method for isolating and using same |
06/17/2010 | US20100150879 Methods for the detection, isolation, and use of lipid phosphate phosphatase-3-positive stem cells |
06/17/2010 | US20100150878 Dermal micro-organs, methods and apparatuses for producing and using the same |
06/17/2010 | US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases |
06/17/2010 | US20100150876 Endodermal progenitor cells |
06/17/2010 | US20100150875 Indefinite culture of human adult glia without immortalization and therapeutic uses thereof |
06/17/2010 | US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
06/17/2010 | US20100150837 ANTIBODIES AGAINST GPIb alpha |
06/17/2010 | CA2773051A1 Method for isolating cellular products by cryopreservation |
06/17/2010 | CA2747244A1 Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis |
06/17/2010 | CA2746668A1 Bioactive grafts and composites |
06/17/2010 | CA2746514A1 Gnaq targeted dsrna compositions and methods for inhibiting expression |
06/17/2010 | CA2744445A1 Primed cell therapy |
06/17/2010 | CA2688804A1 Polycistronic vector for human induced pluripotent stem cell production |
06/17/2010 | CA2647664A1 Systems and methods for cryopreservation of cells |
06/16/2010 | EP2196541A1 Anti-glypican-3 antibody having improved kinetics in plasma |
06/16/2010 | EP2196540A2 Combinatorial DNA library for producing modified N-Glycans in lower eukaryotes |
06/16/2010 | EP2196536A1 Methods for production of proteins |
06/16/2010 | EP2196473A1 Mycobacterial antigens expressed during latency |
06/16/2010 | EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
06/16/2010 | EP2196202A1 Inflammation-inhibiting compounds Lys-Pro-Thr and Lys-Pro |
06/16/2010 | EP2195439A1 Use of aav replication machinery for improved protein production |
06/16/2010 | EP2195429A2 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
06/16/2010 | EP2195417A1 Regionalised endoderm cells and uses thereof |
06/16/2010 | EP2195346A1 Dendritic cell marker and uses thereof |
06/16/2010 | EP2195345A2 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
06/16/2010 | EP2195038A1 Compositions suitable for treatment of spinal disease, disorder or condition |
06/16/2010 | EP2194993A2 Non-invasive in vivo imaging and methods for treating type i diabetes |
06/16/2010 | EP2194992A1 Epidermal stimulation to enhance hair follicle formation |
06/16/2010 | EP1627917B1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO |
06/16/2010 | EP1495125B1 Vac-bac shuttle vector system |
06/16/2010 | CN1911961B Application of paddy rice flower meristem control gene EG1 |
06/16/2010 | CN1608129B Alkaline protease from bacillus sp. (DSM 14392) and uses thereof |
06/16/2010 | CN1500095B Polymer conjugates of neublastin and methods of using ssame |
06/16/2010 | CN1487996B Transgenic transchromosomal rodents for making human antibodies |